Organoid Sample Preparation and Extraction for LC-MS Peptidomics
This protocol describes the peptidomic analysis of organoid lysates, FACS-purified cell populations, and 2D culture secretions by liquid chromatography mass spectrometry (LC-MS). Currently, most peptides are quantified by ELISA, limiting the peptides that can be studied. However, an LC-MS-based appr...
Saved in:
Published in | STAR protocols Vol. 1; no. 3; p. 100164 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
18.12.2020
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This protocol describes the peptidomic analysis of organoid lysates, FACS-purified cell populations, and 2D culture secretions by liquid chromatography mass spectrometry (LC-MS). Currently, most peptides are quantified by ELISA, limiting the peptides that can be studied. However, an LC-MS-based approach allows more peptides to be monitored. Our group has previously used LC-MS for tissue peptidomics and secretion of enteroendocrine peptides from primary culture. Now, we extend the use to organoid models.
For complete details on the use and execution of this protocol, please refer to Goldspink et al. (2020).
[Display omitted]
•Preparing organoid cultures, secretions, and FAC-sorted cells for peptidomics•An established pipeline covering peptide extraction, LC-MS, and data analysis•Unambiguous detection of closely related peptide hormones•Semi-quantitative analysis of secreted peptides from stimulated organoid cultures
This protocol describes the peptidomic analysis of organoid lysates, FACS-purified cell populations, and 2D culture secretions by liquid chromatography mass spectrometry (LC-MS). Currently, most peptides are quantified by ELISA, limiting the peptides that can be studied. However, an LC-MS-based approach allows more peptides to be monitored. Our group has previously used LC-MS for tissue peptidomics and secretion of enteroendocrine peptides from primary culture. Now, we extend the use to organoid models. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lead Contact Present address: Novel Human Genetics, GSK Medicines Research Centre, Stevenage, UK Present address: Université Paris-Saclay, AgroParisTech, INRAE, UMR PNCA, 75005 Paris, France Technical Contact These authors contributed equally |
ISSN: | 2666-1667 2666-1667 |
DOI: | 10.1016/j.xpro.2020.100164 |